All you need to get started with ETF selection and analysis. Create your account now →
Help us improve your experience. Please confirm your investor type:
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.
ETFs with exposure to Pfizer Inc. (PFE)
6.46% | +3.78% | -5.57% | +€2.5M | +€12M | €47M | 0.59% | Not rated | |
First Trust Morningstar Dividend Leaders Index Fund ETF - USD This ETF provides exposure to Other US Equities, excluding REIT | 6.09% | -0.32% | +12.76% | +€97M | +€519M | €6.4B | 0.43% | |
First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) - CAD This ETF provides exposure to Other US Equities, excluding REIT | 6.09% | -2.49% | +9.38% | -€2.6K | +€243K | €7M | 0.59% | Not rated |
CI Health Care Giants Covered Call ETF - USD This ETF provides exposure to Equally Weighted Large Cap North American Health Care Equities | 4.95% | +5.56% | +2.26% | +€1.2M | +€1.2M | €3.7M | 0.73% | Not rated |
CI Health Care Giants Covered Call ETF - CAD This ETF provides exposure to Equally Weighted Large Cap North American Health Care Equities | 4.95% | +8.18% | +5.67% | +€794K | +€767K | €4M | 0.72% | Not rated |
CI Health Care Giants Covered Call ETF - CAD Hedged This ETF provides exposure to Equally Weighted Large Cap North American Health Care Equities | 4.95% | +5.37% | +1.44% | +€7.2M | +€15M | €77M | 0.71% | Not rated |
Invesco Dynamic Pharmaceuticals ETF - USD This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities | 4.85% | +9.54% | +13.11% | -€9.9M | -€204K | €311M | 0.57% | |
4.80% | +6.09% | +6.09% | -€41M | -€340M | €810M | 0.36% | ||
4.70% | +5.42% | +1.56% | €0 | +€1.3M | €3.8M | 0.59% | Not rated | |
4.48% | +0.71% | +12.76% | -€311K | -€1.3M | €52M | 1.04% | ||
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
